CA2178684A1 - Anthracycline prodrugs, method for preparation as well as their use in selective chemotherapy - Google Patents

Anthracycline prodrugs, method for preparation as well as their use in selective chemotherapy

Info

Publication number
CA2178684A1
CA2178684A1 CA002178684A CA2178684A CA2178684A1 CA 2178684 A1 CA2178684 A1 CA 2178684A1 CA 002178684 A CA002178684 A CA 002178684A CA 2178684 A CA2178684 A CA 2178684A CA 2178684 A1 CA2178684 A1 CA 2178684A1
Authority
CA
Canada
Prior art keywords
formula
ome
compound
reaction
carbamate
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002178684A
Other languages
English (en)
French (fr)
Inventor
Ruben Gerardus George Leenders
Eric Wilhelmus Petrus Damen
Johan Wilhelm Scheeren
Hidde Jacob Haisma
Pieter Herman Johannes Houba
Dick De Vos
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pharmachemie BV
Original Assignee
Pharmachemie BV
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharmachemie BV filed Critical Pharmachemie BV
Publication of CA2178684A1 publication Critical patent/CA2178684A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/20—Carbocyclic rings
    • C07H15/203—Monocyclic carbocyclic rings other than cyclohexane rings; Bicyclic carbocyclic ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic Table
    • C07F7/02—Silicon compounds
    • C07F7/08—Compounds having one or more C—Si linkages
    • C07F7/18—Compounds having one or more C—Si linkages as well as one or more C—O—Si linkages
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/20—Carbocyclic rings
    • C07H15/24—Condensed ring systems having three or more rings
    • C07H15/252—Naphthacene radicals, e.g. daunomycins, adriamycins

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Steroid Compounds (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
CA002178684A 1995-06-27 1996-06-10 Anthracycline prodrugs, method for preparation as well as their use in selective chemotherapy Abandoned CA2178684A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP95201747A EP0751144B1 (de) 1995-06-27 1995-06-27 Anthracyclin Prodrugs, Verfahren zu deren Herstellung und deren Verwendung in der selektiven Chemotherapie
EP95201747.3 1995-06-27

Publications (1)

Publication Number Publication Date
CA2178684A1 true CA2178684A1 (en) 1996-12-28

Family

ID=8220425

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002178684A Abandoned CA2178684A1 (en) 1995-06-27 1996-06-10 Anthracycline prodrugs, method for preparation as well as their use in selective chemotherapy

Country Status (9)

Country Link
US (1) US5710135A (de)
EP (1) EP0751144B1 (de)
JP (1) JPH0912591A (de)
AT (1) ATE278700T1 (de)
CA (1) CA2178684A1 (de)
DE (1) DE69533615T2 (de)
DK (1) DK0751144T3 (de)
ES (1) ES2227536T3 (de)
PT (1) PT751144E (de)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19720312A1 (de) * 1997-05-15 1998-11-19 Hoechst Ag Zubereitung mit erhöhter in vivo Verträglichkeit
US6180095B1 (en) 1997-12-17 2001-01-30 Enzon, Inc. Polymeric prodrugs of amino- and hydroxyl-containing bioactive agents
WO1999030727A1 (en) 1997-12-17 1999-06-24 Enzon, Inc. Polymeric prodrugs of amino- and hydroxyl-containing bioactive agents
US6624142B2 (en) 1997-12-30 2003-09-23 Enzon, Inc. Trimethyl lock based tetrapartate prodrugs
US5965119A (en) * 1997-12-30 1999-10-12 Enzon, Inc. Trialkyl-lock-facilitated polymeric prodrugs of amino-containing bioactive agents
US6214330B1 (en) 1998-07-13 2001-04-10 Enzon, Inc. Coumarin and related aromatic-based polymeric prodrugs
US6043367A (en) * 1998-09-30 2000-03-28 Roffler; Steve Proactive antitumor compounds
EP1343494A4 (de) * 2000-12-01 2005-08-03 Enzon Inc Tetrapartat-prodrugs
AU2002251988A1 (en) * 2001-02-20 2002-09-04 Enzon, Inc. Terminally-branched polymeric linkers and polymeric conjugates containing the same
AU2002320964B2 (en) * 2001-08-14 2008-03-13 Valderm Aps Treatment of hyperproliferative conditions of body surfaces
US20040038904A1 (en) * 2002-05-21 2004-02-26 Angela Ogden Method of treating multiple sclerosis
EP2357009A1 (de) 2002-07-15 2011-08-17 Board of Regents, The University of Texas System Duramycin-peptid mit bindung an anionische Phospholipide und Aminophospholipide Konjugate und ihre Verwendung bei der Behandlung von Virusinfektionen
ES2572356T3 (es) 2007-11-09 2016-05-31 Peregrine Pharmaceuticals Inc Composiciones de anticuerpos dirigidos contra VEGF y procedimientos
EP2098533A1 (de) * 2008-03-07 2009-09-09 Pharmachemie B.V. Ester aus Glucuronid-Prodrugs von Anthracyclinen und Verfahren zu deren Herstellung und Verwendung bei der tumorselektiven Chemotherapie
EP2538929A4 (de) 2010-02-25 2014-07-09 Univ Johns Hopkins Verzögerte freisetzung von therapiemitteln in einen teil des auges
US10307372B2 (en) 2010-09-10 2019-06-04 The Johns Hopkins University Rapid diffusion of large polymeric nanoparticles in the mammalian brain
WO2012109363A2 (en) 2011-02-08 2012-08-16 The Johns Hopkins University Mucus penetrating gene carriers
CA2863632C (en) 2012-01-19 2017-07-11 The Johns Hopkins University Nanoparticle formulations with enhanced mucosal penetration
JP6138904B2 (ja) 2012-03-16 2017-05-31 ザ・ジョンズ・ホプキンス・ユニバーシティー 活性剤の送達のための非線状マルチブロックコポリマー薬物コンジュゲート
US8962577B2 (en) 2012-03-16 2015-02-24 The Johns Hopkins University Controlled release formulations for the delivery of HIF-1 inhibitors
AU2013256008B2 (en) 2012-05-04 2016-02-25 The Johns Hopkins University Lipid-based drug carriers for rapid penetration through mucus linings
US9533068B2 (en) 2012-05-04 2017-01-03 The Johns Hopkins University Drug loaded microfiber sutures for ophthalmic application
CN103910875B (zh) * 2012-12-31 2017-06-13 张雅珍 蒽环类抗生素偶联非线性多嵌段共聚物及其制备方法和应用
WO2014124006A1 (en) 2013-02-05 2014-08-14 The Johns Hopkins University Nanoparticles for magnetic resonance imaging tracking and methods of making and using thereof
WO2015127368A1 (en) 2014-02-23 2015-08-27 The Johns Hopkins University Hypotonic microbicidal formulations and methods of use
CN107635545A (zh) 2015-01-27 2018-01-26 约翰霍普金斯大学 用于增强粘膜表面处活性剂的输送的低渗水凝胶制剂
US12496279B2 (en) 2019-04-11 2025-12-16 The Johns Hopkins University Nanoparticles for drug delivery to brain

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0048041A3 (en) * 1978-03-27 1982-08-04 Discovision Associates Method and apparatus for writing a signal-information track by using a radiation beam
DE4002888A1 (de) 1990-02-01 1991-08-08 Behringwerke Ag Anthracyclin-glycosyl-prodrugs, verfahren zu ihrer herstellung und ihre verwendung in kombination mit funktionalisierten tumorspezifischen enzymkonjugaten
FR2676058B1 (fr) 1991-04-30 1994-02-25 Hoechst Lab Prodrogues glycosylees, leur procede de preparation et leur utilisation dans le traitement des cancers.
DE4236237A1 (de) 1992-10-27 1994-04-28 Behringwerke Ag Prodrugs, ihre Herstellung und Verwendung als Arzneimittel

Also Published As

Publication number Publication date
DE69533615D1 (de) 2004-11-11
JPH0912591A (ja) 1997-01-14
EP0751144A1 (de) 1997-01-02
ES2227536T3 (es) 2005-04-01
PT751144E (pt) 2004-12-31
DK0751144T3 (da) 2004-12-27
US5710135A (en) 1998-01-20
ATE278700T1 (de) 2004-10-15
DE69533615T2 (de) 2005-10-13
EP0751144B1 (de) 2004-10-06

Similar Documents

Publication Publication Date Title
CA2178684A1 (en) Anthracycline prodrugs, method for preparation as well as their use in selective chemotherapy
Deutsch et al. Synthesis of congeners and prodrugs. 3. Water-soluble prodrugs of taxol with potent antitumor activity
KR0169496B1 (ko) 2-데옥시-2,3-디데히드로-n-아세틸 뉴라민산의 유도체 및 유사체 및 그의 항비루스제로서의 용도
DK2955190T3 (en) Chemical compounds
AU610344B2 (en) 2'-deoxy-5-fluorouridine derivatives
JP3773153B2 (ja) シアル酸誘導体
JPH09202796A (ja) 新規なパクリタキセルプロドラッグ、製造方法およびその選択的化学療法における使用
CZ299840B6 (cs) Nové aromatické amidy, jejich postup prípravy a jejich použití jako léciva
JPH06506687A (ja) グリコシル化したプロドラック、その製法と用途
JP5778145B2 (ja) 抗癌剤としてのベンゾキノリジニウム塩誘導体
Meng et al. Synthesis of 2′-paclitaxel 2-deoxy-2-fluoro-glucopyranosyl carbonate for specific targeted delivery to cancer cells
Bouvier et al. First enzymatically activated Taxotere prodrugs designed for ADEPT and PMT
Wei et al. β-Glucuronidase-cleavable prodrugs of O 6-benzylguanine and O 6-benzyl-2 ‘-deoxyguanosine
US20090227617A1 (en) Esters Of Glucuronide Prodrugs Of Anthracyclines And Method Of Preparation And Use In Tumor-Selective Chemotherapy
FI89494C (fi) Foerfarande foer framstaellning av nya sackaridderivat
PL211566B1 (pl) Analog 2',5'-oligoadenylanowy, kompozycja farmaceutyczna zawierająca analog 2',5'-oligoadenylanowy oraz zastosowanie analogu 2',5'-oligoadenylanowego
DK168597B1 (da) 4-substituerede demethoxy-daunomydinoner og anthracyclinglycosider deraf samt fremgangsmåde til fremstilling af glycosiderne
CA2286181A1 (en) Anti-cancer drug aldehyde conjugate drugs with enhanced cytotoxicity: compounds, compositions and methods
FI78109C (fi) Foerfarande foer framstaellning av antracyklinglykosider.
Sriharsha et al. Synthesis and antimicrobial activity of novel 1, 3-oxazolidine nucleoside analogues
PL205635B1 (pl) Nowe pochodne genisteiny i zawierające je środki farmaceutyczne
Nagy et al. Synthesis of some O-, S-and N-glycosides of hept-2-ulopyranosonamides
JPH02178299A (ja) エピポドフィロトキシングルコシドの糖ホスフェート類及びスルホネート類
EP1438319A1 (de) Etiposidderivate und analoga, und diese enthaltende pharmazeutische zusammensetzungen
KR20220005013A (ko) 시티딘 유도체 및 시티딘 유도체의 형성 방법

Legal Events

Date Code Title Description
EEER Examination request
FZDE Discontinued